Skip to main content
CVS
NYSE Trade & Services

CVS to Split Into Two Public Companies, Tax-Free, by First Half of 2028

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Consumer
Sentiment info
Positive
Importance info
9
Price
$91.86
Mkt Cap
$116.911B
52W Low
$69.51
52W High
$110.68
52W Position info
32% above low
Off High info
17% below high
Rel. Volume info
2.4× avg
Market data snapshot near publication time

CVS sits 32% above its 52-week low of $69.51 on elevated volume (2.4× avg).

Summary

CVS plans to separate into two independent public companies — a healthcare solutions business and CVS Pharmacy — in a transaction intended to be tax-free to shareholders, targeted for completion in the first half of 2028.


Key Events · M&A and Partnerships · CVS

  • CVS Announces Two-Company Separation

    Board-approved plan to split into a healthcare solutions company (Aetna, CVS Caremark, CVS Specialty, Oak Street Health, Signify Health) and CVS Pharmacy (approximately 9,000 pharmacies, mail pharmacy, MinuteClinic, Health100).

  • Tax-Free Structure, 1H 2028 Target

    Separation is intended to be tax-free to CVS Health and its shareholders for U.S. federal income tax purposes, with completion expected in the first half of 2028.

  • Leadership Named for Both Companies

    David Joyner, currently Chairman and CEO of CVS Health, will chair and run the healthcare solutions company; Prem Shah, currently Group President, will be CEO of CVS Pharmacy.

  • Conditions Still Outstanding

    Completion is subject to final board approval, effectiveness of a Form 10 registration statement with the SEC, and receipt of customary confirmation of tax-free treatment; additional leaders and board members will be announced later.


Analysis · CVS · Trade & Services

CVS is breaking itself in two: a healthcare solutions company (Aetna, Caremark, Specialty, Oak Street, Signify) and CVS Pharmacy (about 9,000 stores, MinuteClinic, Health100). The split is intended to be tax-free to shareholders, with both companies expected to carry solid investment grade ratings and pay attractive dividends. For a $117 billion company, this is a thesis-altering event — it changes what investors own, how each business is valued, and who runs each piece (Joyner at the solutions company, Shah at the pharmacy company). The long runway matters: completion is targeted for the first half of 2028, subject to board final approval, an effective Form 10 registration, and tax-free confirmation, so the structure can still change. It follows press reports of spin-off talks on 2026-11-03 and lands the same morning as Q3 results and raised guidance, which gives management a stronger hand going into the separation.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 52.4% of the 208 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -1.91%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, CVS was trading at $91.86 on NYSE in the Trade & Services sector, with a market capitalization of approximately $116.9B. The 52-week trading range was $69.51 to $110.68. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CVS - Latest Insights

CVS
Nov 04, 2026, 1:48 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $80.13
Real-time Price: $79.92 info
Change: -$0.2087 (-0.26%) info
Market Cap: $103.433B info
CVS
Nov 04, 2026, 6:41 AM EST
Source: Reuters
Importance Score:
9
Price at Filing: $93.20
Real-time Price: $79.92 info
Change: -$13.28 (-14%) info
Market Cap: $103.433B info
CVS
Nov 04, 2026, 6:31 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $91.49
Real-time Price: $79.92 info
Change: -$11.57 (-13%) info
Market Cap: $103.433B info
CVS
Nov 04, 2026, 6:30 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $91.84
Real-time Price: $79.92 info
Change: -$11.92 (-13%) info
Market Cap: $103.433B info
CVS
Nov 03, 2026, 5:35 PM EST
Source: Reuters
Importance Score:
9
Price at Filing: $94.00
Real-time Price: $79.92 info
Change: -$14.08 (-15%) info
Market Cap: $103.433B info